ACYP2 functions as an innovative nano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathwayYixuan Wu(Nantong University), Feng Wang(Nantong University)Journal of NanobiotechnologySeptember 12, 202410.1186/s12951-024-02827-4Cited by 6SaveCiteExport RISWatch citationsRelated PapersRoles of Noncoding RNAs in the Initiation and Progression of Myocardial Ischemia-Reperfusion Injury|Epigenomics|2021|15